Podcasts about immunologist

What good is a vaccine people don't trust? Immunologist and TED Fellow Kizzmekia Corbett co-developed the first COVID-19 vaccine to enter clinical trials — but she'll tell you that making the vaccine was never the hardest part. The real obstacle is the gap between scientists and the people who have honest questions about the shots they're being asked to take. She shares a refreshing approach for taking on vaccine inquisitiveness and ensuring that humanity is ready for the next pandemic. And stick around after her talk for a deep dive conversation with our guest host for the week, author and podcaster Manoush Zomorodi, into the ideas she shared on stage and beyond.This is episode three of a seven-part series airing this week on TED Talks Daily, where Manoush — and the seven speakers she curated for TED2026 — explore how you can live a healthier life in our high-tech era.To hear more from Manoush, listen to TED Radio Hour wherever you get your podcasts. Check out her new book, Body Electric, to learn more about the hidden health costs of the digital age Hosted on Acast. See acast.com/privacy for more information.

Dr. Elisabeth Marnik is not your average immunologist.  Because she grew up unvaccinated, she has a special insight into why people choose to opt out of vaccine schedules and what can be done to build trust and increase vaccine acceptance. This week on Say More, Dr. Marnik, who is also the executive director of the Evidence Collective, sat down with Say More's Anna Kusmer to talk about vaccine mandates, the limits of empathy, and why “facts alone are not enough.” Email us at saymore@globe.com. From the Science Classroom by Science Whiz Liz Eureka Day, now playing at the Huntington Theater.

Nicholas Jackson, AKA Nick the Immunologist, talks about being a graduate student, social media creator, and his research on cytokine tools to investigate regulatory T cells. Host: Cindy Leifer Guest: Nicholas Jackson (Nick the Immunologist) Subscribe (free): Apple Podcasts, RSS, email Become a patron of Immune! Links for this episode MicrobeTV Discord Server Richard DiPaolo lab IL-2, TGFb and Tregs preprint Nick the Immunologist on TikTok Nick the Immunologist on Instagram Time stamps by Jolene Ramsey. Thanks! Music by Tatami. Logo image by Blausen Medical Send your immunology questions and comments to immune@microbe.tv Information on this podcast should not be construed as medical advice.

This week on The Hamilton Review Podcast, we're pleased to welcome Dr. Akansha Ganju.  Dr. Akansha Ganju is a board-certified allergist and immunologist with a passion for delivering comprehensive, patient-centered care for both adults and children with allergic conditions. She leads Latitude's Los Angeles clinic in West LA, providing specialized life-changing care for food allergy patients of all ages. In this must listen episode, Dr. Ganju discusses food allergies in children and the steps an immunologist can take to diagnose and create a personalized treatment plan for the child and their family. Prior to joining the Latitude team, Dr. Ganju was the Medical Director at Nectar Allergy Center where she played a pivotal role in developing and expanding the startup's inaugural clinic for innovative allergy treatment.  Dr. Ganju graduated from an accelerated, combined baccalaureate-M.D. program and received her medical degree from Northeast Ohio Medical University. She is board-certified in internal medicine and completed her residency at Riverside Methodist Hospital in Columbus, Ohio. She went on to complete her allergy and immunology fellowship at UCLA and the VA Greater Los Angeles Healthcare System. Dr. Ganju has authored numerous publications in peer-reviewed journals, conducted both basic science and clinical research, and often presents at healthcare conferences. She is a member of the American Academy of Allergy, Asthma & Immunology (AAAAI) and American College of Allergy, Asthma, and Immunology (ACAAI).  How to contact Dr. Akansha Ganju:   Dr. Akansha Ganju on Instagram   Latitude Food Allergy Care   Latitude Food Allergy Care on Instagram   Latitude Food Allergy Care on Facebook     How to contact Dr. Bob: Dr. Bob on YouTube: https://www.youtube.com/channel/UChztMVtPCLJkiXvv7H5tpDQ Dr. Bob on Instagram: https://www.instagram.com/drroberthamilton/ Dr. Bob on Facebook: https://www.facebook.com/bob.hamilton.1656 Dr. Bob's Seven Secrets Of The Newborn website: https://7secretsofthenewborn.com/ Dr. Bob's website: https://roberthamiltonmd.com/ Pacific Ocean Pediatrics: http://www.pacificoceanpediatrics.com/    

Send us Fan Mail

Interview with Iwona Koenig, PhD

Send us Fan Mail

Καλεσμένη η κα. Αναστασία Διέτη, κυτταρικός ανοσολόγος, με ειδικότητα στους ρυθμιστικούς μηχανισμούς σε αυτοάνοσες παθήσεις.   Κάθε φορά που αρρωσταίνουμε, ο οργανισμός μας αναγνωρίζει τον εισβολέα, κινητοποιεί τις άμυνές του και αν όλα πάνε καλά, τον εξουδετερώνει. Τι γίνεται όμως όταν αυτός ο μηχανισμός χάσει τον προσανατολισμό του και στραφεί εναντίον μας; Με αφορμή την Παγκόσμια Ημέρα Ανοσολογίας, στις 29 Απριλίου, μιλάμε για αυτόν τον καθοριστικό μηχανισμό: το ανοσοποιητικό μας σύστημα. Στο σημερινό επεισόδιο θα μιλήσουμε για το ανοσοποιητικό μας σύστημα, τα αυτοάνοσα νοσήματα και πώς μπορούμε να τα διαχειριστούμε. Παράλληλα, θα εξετάσουμε τον ρόλο της διατροφής, του ύπνου και της καθημερινότητας, θα δούμε πού βρίσκεται σήμερα η έρευνα στην ανοσολογία και πώς η ανοσοθεραπεία αλλάζει τα δεδομένα, ακόμη και στη θεραπεία του καρκίνου.

Send us Fan Mail

Ticks & Stars 4/16/26: Immunologist Dr Jonathan Bayuk: flu, measles, covid, Lyme, EEE & West Nile. “Young@Heart Meets Y@H NYC:” local stars Bob Cilman & Sonya Nieto w/ NYC stars Evette Mercedes, Patrick McCarthy & Wayne Brockman. MTA Pres Max Page: the House budget just dropped. “An All-Star Klezmer Evening” w/ Jake Shulman-Ment & Ira Temple. Gld Recorder & DHG Ex Ed Dan Crowley: breaking news, overrides & Hampshire Coll closing.

Guests:Dr Eoin O'Cearbhaill, Associate Professor in Biomedical Engineering at University College DublinDr Shane Bergin, Physicist at UCDDr Lara Dungan, Immunologist and Medic

Professor Michaela Lucas, an Immunologist and Immunopathologist researching the health impacts of plastics, joins me to explore what microplastics and plastic-associated chemicals may be doing inside our bodies. We discuss how compounds like bisphenols and phthalates can act like hormone-mimicking molecules, the evidence linking plastic exposure to developmental and fertility concerns, and why some estimates of microplastics in the body may have been overstated. Professor Lucas also shares insights from her ongoing study in Perth examining how everyday exposures, particularly ultra-processed foods packaged in plastic, may contribute to microplastics in the body. Listeners can subscribe to receive the study results when they're released via www.uwa.edu.au/projects/the-perth-trial. Linkedin: @prof-michaela-lucas/  

Immunologist Reveals the Real Cause of Skin Aging - Dr. Ebru Karpuzoglu What if your wrinkles, breakouts, and sagging skin aren't aging problems… but immune system problems? What if true radiance starts at the cellular level—not in your makeup bag? In this powerful episode of the Balanced, Beautiful & Abundant podcast, Rebecca Whitman sits down with immunologist and molecular medicine specialist Dr. Ebru Karpuzoglu to uncover the truth about skin aging, chronic inflammation, and what most skincare brands aren't telling you. With over 30 years of research studying how the immune system, hormones, and inflammation impact the skin, Dr. Ebru realized something shocking: traditional skincare treats symptoms—not root causes. After witnessing how cancer treatments affected her father's skin—and struggling with her own skin challenges—she set out to create a science-backed solution that supports the skin barrier and microbiome at the cellular level. Her groundbreaking work led to the development of Dermoimmuno Beauty Technology and the creation of AveSeena—an award-winning skincare line trusted by scientists, physicians, and skincare lovers worldwide. In this episode, we discuss: ✨ What “inflammaging” really is—and how it accelerates visible aging ✨ How chronic stress and cortisol damage your skin ✨ Why hormonal changes in midlife transform your complexion ✨ The truth about the skin microbiome and barrier health ✨ Daily habits that unknowingly speed up aging ✨ The top 3 things you can do now to support youthful, resilient skin If you care about longevity, vitality, and aging powerfully—not fearfully—this conversation will completely shift how you approach beauty. Because radiant skin isn't about covering up. It's about healing from within. Connect with Dr. Ebru: https://www.aveseena.com/shop/dehydration/anka-treatment-system/ Promo code LOVETHIS If this episode expanded your perspective, please subscribe, share, and leave a review. It helps more women discover how to live balanced, beautiful, and abundant—inside and out.

Immunologist Reveals the Real Cause of Skin Aging - Dr. Ebru Karpuzoglu What if your wrinkles, breakouts, and sagging skin aren't aging problems… but immune system problems? What if true radiance starts at the cellular level—not in your makeup bag? In this powerful episode of the Balanced, Beautiful & Abundant podcast, Rebecca Whitman sits down with immunologist and molecular medicine specialist Dr. Ebru Karpuzoglu to uncover the truth about skin aging, chronic inflammation, and what most skincare brands aren't telling you. With over 30 years of research studying how the immune system, hormones, and inflammation impact the skin, Dr. Ebru realized something shocking: traditional skincare treats symptoms—not root causes. After witnessing how cancer treatments affected her father's skin—and struggling with her own skin challenges—she set out to create a science-backed solution that supports the skin barrier and microbiome at the cellular level. Her groundbreaking work led to the development of Dermoimmuno Beauty Technology and the creation of AveSeena—an award-winning skincare line trusted by scientists, physicians, and skincare lovers worldwide. In this episode, we discuss: ✨ What “inflammaging” really is—and how it accelerates visible aging ✨ How chronic stress and cortisol damage your skin ✨ Why hormonal changes in midlife transform your complexion ✨ The truth about the skin microbiome and barrier health ✨ Daily habits that unknowingly speed up aging ✨ The top 3 things you can do now to support youthful, resilient skin If you care about longevity, vitality, and aging powerfully—not fearfully—this conversation will completely shift how you approach beauty. Because radiant skin isn't about covering up. It's about healing from within. Connect with Dr. Ebru: https://www.aveseena.com/shop/dehydration/anka-treatment-system/ Promo code LOVETHIS If this episode expanded your perspective, please subscribe, share, and leave a review. It helps more women discover how to live balanced, beautiful, and abundant—inside and out.

  What if your wrinkles, breakouts, and sagging skin aren't aging problems… but immune system problems? What if true radiance starts at the cellular level—not in your makeup bag?   In this powerful episode of the Balanced, Beautiful & Abundant podcast, Rebecca Whitman sits down with immunologist and molecular medicine specialist Dr. Ebru Karpuzoglu to uncover the truth about skin aging, chronic inflammation, and what most skincare brands aren't telling you.   With over 30 years of research studying how the immune system, hormones, and inflammation impact the skin, Dr. Ebru realized something shocking: traditional skincare treats symptoms—not root causes.   After witnessing how cancer treatments affected her father's skin—and struggling with her own skin challenges—she set out to create a science-backed solution that supports the skin barrier and microbiome at the cellular level.   Her groundbreaking work led to the development of Dermoimmuno Beauty Technology and the creation of AveSeena—an award-winning skincare line trusted by scientists, physicians, and skincare lovers worldwide.   In this episode, we discuss:   ✨ What “inflammaging” really is—and how it accelerates visible aging ✨ How chronic stress and cortisol damage your skin ✨ Why hormonal changes in midlife transform your complexion ✨ The truth about the skin microbiome and barrier health ✨ Daily habits that unknowingly speed up aging ✨ The top 3 things you can do now to support youthful, resilient skin   If you care about longevity, vitality, and aging powerfully—not fearfully—this conversation will completely shift how you approach beauty.   Because radiant skin isn't about covering up. It's about healing from within.   Connect with Dr. Ebru: https://www.aveseena.com/shop/dehydration/anka-treatment-system/   Promo code LOVETHIS   If this episode expanded your perspective, please subscribe, share, and leave a review. It helps more women discover how to live balanced, beautiful, and abundant—inside and out.

“I do not believe we should be testing to test. We have to know, is this test going to change management and is it going to make a difference,” says pediatric allergist-immunologist Dr. Zachary Rubin. His knack for providing that sort of straightforward guidance explains why Dr. Rubin has become a trusted voice on allergies, asthma, and vaccines for his millions of followers on social media platforms. It's also why we couldn't ask for a better guide for our discussion on the rise in allergies, asthma, and immune-related conditions in children, and how families can navigate the quickly evolving science and rampant misinformation in the space. On this episode of Raise the Line, we also preview Dr. Rubin's new book, All About Allergies, in which he breaks down dozens of conditions and diseases, offering clear explanations and practical treatment options for families. Join host Lindsey Smith for this super informative conversation in which Dr. Rubin shares his thoughts on a wide range of topics including: What's behind the rise in allergic and immune-related conditions.Tips for managing misinformation, myths and misunderstandings. How digital platforms can be leveraged to strengthen public health.How to build back public trust in medicine.Mentioned in this episode:All About Allergies bookBench to Bedside PodcastInstagramTikTokYouTube Channel If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Measles is making a comeback, chicken pox hides in your brain and — once more — we discuss why vaccines don’t cause autism with immunologist Dr. Chris Mayne. The Viterbo University biology professor joins us as Wisconsin sees its first case of measles — a University of Wisconsin student — and as outbreaks occur in ICE detention facilities and in various states — mostly amongst kids. Mayne explains that measles is the most contagious virus known to man — there are already more cases in 2026 than in all of 2024 — how vaccine hesitancy is fueling a resurgence, and why the virus is so dangerous. Mayne also explains how the autism-vaccine hoax began.See omnystudio.com/listener for privacy information.

The Natural Nurse, Ellen Kamhi, talks with Dr. Dean Mitchell, a board-certified allergist, immunologist, and integrative medicine specialist with over 25 years of experience. He is the founder of Mitchell Medical Group in New York City and a national leader in sublingual immunotherapy, a safer and more natural treatment for allergies. Dr. Mitchell is the author of Dr. Dean Mitchell's Allergy and Asthma Solution, which offers an innovative, holistic approach to managing immune and allergic conditions. A graduate of NYU School of Medicine, he is also the host of the Smart Medicine podcast, where he explores cutting-edge strategies for treating chronic illness and restoring vibrant health.  www.mitchellmedicalgroup.com

Oral Alpan, MD, Immunologist, Amerimmune, Virginia, USA; Svenja Keller, PhD student, University of Zurich, Switzerland; Shoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Patrick Deegan, MD, Consultant Metabolic Physician, University of Cambridge, UK; and Ravi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health System, Virginia, USA, discuss the applications of AI in the diagnosis and treatment of lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session4-expanded-applications-of-ai-in-lysosomal-disorders/Learning ObjectivesDescribe how emerging AI and machine learning technologies are advancing disease modeling and biomarker development.Describe how emerging AI and machine learning technologies are advancing therapeutic target identification across lysosomal disorders.FacultyOral Alpan, MD, Immunologist, AmerimmuneSvenja Keller, PhD student, University of ZurichShoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical CenterPatrick Deegan, MD, Consultant Metabolic Physician, University of CambridgeRavi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health SystemDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Oral Alpan, MD Dr. Alpan has no relevant financial relationships to disclose.Svenja KellerMs. Keller has no relevant financial relationships to disclose.Shoshana Revel-Vilk, MD, PhDDr. Revel-Vilk receives grant/research support from Sanofi and Takeda. She is a member of the Speakers Bureau for Sanofi and Takeda, and a member of the Advisory Board for Takeda.Patrick Deegan, MDDr. Deegan is a consultant and advisory board member with Sanofi, Takeda, and Amicus.He also receives research support from Sanofi and Amicus.Ravi Kamath, MD, PhDDr. Kamath is on an advisory board for Intrinsic Therapeutics. He is also a consultant forSanofi, Takeda, and Spur Therapeutics.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

Send us a textWhat if beauty isn't something we chase, but something we cultivate from within? In this week's episode, Camille is joined by Dr. Ebru Karpuzoglu (EH-broo KAR-poo-ZOH-loo), an Immunologist trained in Molecular Medicine, founder of AveSeena, and author of Empire of Mirrors: Exposé of Beauty Untold.Together, they explore how science and self-care intertwine to empower women to redefine beauty on their own terms. You'll learn how inflammaging—the chronic, low-grade inflammation linked to aging—impacts both our skin and emotional health, and what small, science-backed rituals can help restore balance, confidence, and vitality.If you've ever struggled with burnout, self-image, or feeling disconnected from your reflection, this conversation will help you see beauty through a new, empowering lens.In this episode, you'll learn: The science behind “inflammaging” and what it means for women's health How emotional wellness and stress directly affect your skin Simple, daily rituals to calm inflammation and restore balance How to redefine beauty through confidence and authenticity What Dr. Ebru uncovered while writing Empire of Mirrors — and how we can reclaim our power from the beauty industryConnect with Dr. Ebru Karpuzoglu: Website: www.aveseena.com Book: Empire of Mirrors: Exposé of Beauty Untold (available wherever books are sold) Instagram: @aveseenaConnect with Camille: www.camillewalker.co Listen to more episodes of Call Me CEO Follow on Instagram: @camillewalker.coIf you loved this episode, please share it with a friend or leave a review — your support helps us reach more women who are ready to lead with clarity, confidence, and care.

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, interview Fei Li Kuang, MD, PhD, an allergist and immunologist, at Northwestern Medicine, about receiving two APFED HOPE on the Horizon Grants. Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:50] Co-host Ryan Piansky introduces this episode, brought to you thanks to the support of Education Partners GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:14] Holly introduces today's topic, two APFED HOPE on the Horizon Pilot Grant Projects and today's guest, Fei Li Kuang, MD, PhD, an Assistant Professor in the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.   [1:42] Dr. Kuang is a physician-scientist who takes care of patients with eosinophilic disorders and also performs laboratory research on these disorders in her lab, often using patient samples. Holly thanks Dr. Kuang for joining us.   [2:05] As a child, Dr. Kuang always wanted to be a scientist. She is so grateful to live out her childhood dream, and it's because of the amazing people who have supported her, most importantly, her parents.   [2:29] In graduate school, Dr. Kuang studied B cells. When she went on to do an allergy fellowship, she thought she would study B cells and care for patients with B cell problems. Instead, she fell in love with allergy and eosinophilic disorders.   [2:50] Dr. Kuang is here, in part, because of the different mentors she has had, and in large part, because of the patients she has met along the way.   [3:20] Dr. Kuang had the opportunity to work with Amy Klion at the NIH in a clinical trial to treat patients with a drug that gets rid of eosinophils. She says it was a dream come true after her training.   [4:02] She says she learned so much about eosinophils, their unusual biology, and the mystery behind what they are here for. She got hooked.   [4:15] Dr. Kuang thinks the patients you meet in a clinical trial in a special place like NIH occupy a space in your heart that makes you want to keep working on the subject area.   [4:34] Patients in a clinical trial have given up a bunch of their time to travel to Bethesda, Maryland. For the trial Dr. Kuang participated in as a Fellow, it was a good year of their time to come out and do it.   [4:47] Dr. Kuang felt there were so many interesting questions, from an intellectual point of view, but there was also a real need from patients with chronic conditions. It was a beautiful opportunity to marry scientists with physicians in training.   [5:36] Dr. Kuang shares some knowledge about eosinophils. They are white blood cells that are in all of us. They have little pink packages or granules that "jumped out" in the light microscope almost 200 years ago, when we first identified them.   [6:00] Dr. Kuang says that animals, dating back to reptiles, and different species of dolphins, all have eosinophils. A veterinary scientist, Dr. Nicole Stacy of the University of Florida, has taken photos of eosinophils from all these different species.   [6:21] They've been around for a long time. What are they good for? What we know is that they are associated with disease conditions, such as asthma and others, including leukemia. Those were the classic first studies of eosinophils.   [6:42] Now, we have a different mindset about eosinophils from work by the late James Lee at Mayo Clinic, Arizona.   [6:58] Dr. Kuang credits Dr. Lee with suggesting that eosinophils not just cause us problems but also help treat parasitic infections, maintain tissue homeostasis, help wound healing, and tissue repair. That's a new area we are beginning to appreciate.   [7:41] Dr. Kuang says we need to be open-minded that in some circumstances, eosinophils may be helpful or innocent. Now we have tools to start to understand some of that. We need to collect information from patients being treated with medicines.   [8:10] Ryan tells of being diagnosed as a kid. Doctors explained to him that eosinophils fight parasites, but in some people, they get confused and attack the esophagus. That's EoE. That was easy to understand, but he knew that the researchers knew more.   [8:53] Ryan is grateful to the patient population around eosinophilic esophagitis, and is proud of APFED's support of patients and caregivers with HOPE Grants. APFED has the HOPE on the Horizon Research Program, entirely funded by community donations.   [9:13] To date, APFED has directed more than $2 million toward eosinophilic disease research initiatives through various grant programs. As a patient advocacy organization, APFED works with fantastic researchers who submit innovative research ideas.   [9:32] These research ideas go through an extensive and competitive peer-review process, supported by researchers and clinicians in the APFED community.   [9:42] Today, we're going to discuss two different projects supported by HOPE Pilot Grants with Dr. Kuang.   [10:00] Dr. Kuang thinks there are two ways these grant programs are important to patients. One is advancing research by nurturing seedling investigators. Dr. Kuang got her first grant when she was a Fellow. It was an incredible opportunity.   [10:25] These grant programs also nurture seedling ideas that don't have enough evidence yet to garner the larger NIH grants, and so forth. There are other sources for grants: pharmaceutical companies. The grant programs are for seeds.   [10:49] Patients need to know that there are new things that are given some chance of being tested out. Research takes some time, and the FDA process of getting a drug approved is long.   [11:04] For the newly diagnosed patient, it can feel overwhelming. It feels like there's a loss of control. Sometimes, participating in something like APFED, being part of a community, gives back a sense of control that is lost when you're handed a diagnosis.   [11:45] For patients who have had it for a long time, when they participate in research and become engaged in organizations like APFED, they know they may not directly benefit today, they may benefit later, but they hope future patients will benefit.   [12:21] That gives them a sense of control and hope that things will be better for the next generation. We all want that, especially in medicine, in something that we don't have a very deep understanding of.   [12:58] Dr. Kuang received two HOPE Pilot Grants, one in 2018 and one in 2022. The first grant was awarded when she was a Fellow at the NIH.   [13:05] That first grant explored some effects of eosinophilic depletion of pathogenic lymphocytes in hypereosinophilic syndrome and overlaps with EGIDs. Ryan asks for a broad overview of that research.   [13:25] When Dr. Kuang was a Fellow at the NIH, they were doing a Phase 2 clinical trial, looking at "blowing up" eosinophils in patients who have a lot of them, hypereosinophilic syndrome patients.   [13:39] They included patients who had eosinophilic GI disease, often beyond the esophagus. They may have esophageal involvement, but sometimes their stomach is impacted, sometimes their large bowel is impacted, with related symptoms.   [13:57] What Dr. Kuang and the team noticed in the trial was that just within that little group of patients, there were people who did well, and people who did much better than before, but would have recurrent symptoms, and with no eosinophils in their GI tissues.    [14:16] The researchers wanted to know what was causing these problems for the patient. If you take eosinophils away, what other factors will impact the immune system of the patient, semi-long-term?   [14:32] Their focus was on these groups of patients who had different responses. They looked at the white blood cells that had been previously described as being the responsible, "bad" T cells that lead to eosinophils in the gut.   [14:49] They found that the patients who had recurrent flares of the disease had more of the bad T cells, and the patients who responded well and never complained again about symptoms did not.   [15:03] That allowed researchers to identify that there were subsets of patients with the disease that they were calling the same thing.   [15:18] Dr. Kuang says that work also led them to find that those cells were being reported in patients who had food allergies for which they needed an epinephrine auto-injector.   [15:27] The researchers were curious whether that was just a food allergy issue, or only applied if you had food allergies and eosinophilic GI disease. That HOPE project allowed them to do a pilot study to look at food allergy patients, too. They did, and published it.   [15:45] They published that in patients who have a food allergy and have these T cells, the insides of those cells make different messages for the immune system than the ones that the researchers had previously described.   [16:01] In looking for why there were differences in those responses, they accidentally found that there were differences inside these cells in a completely different disease, which also had these T cells.   [16:21] Dr. Kuang says that the finding was kind of a surprise. If they had found anything in the eosinophilic GI disease patients, that would have been good. They also looked at the epithelial cells and the structure of the GI lining.   [16:42] Even though there were no eosinophils in the GI lining in the patients who had been treated with a biologic that depleted eosinophils, their GI lining still looked like the GI lining of patients who had eosinophilic GI disease.   [16:55] Dr. Kuang asked what was creating those spots. Our gut lining sheds, so there should have been an opportunity for the GI lining to turn over and look new. Something was there, making signals to create these spots. They did a different publication on that.   [17:21] The data from the HOPE Pilot study allowed Dr. Kuang to apply for larger grants. It allowed her to propose to the company that made this drug, when they did the Phase 3 trial, to insert into that special study the study on eosinophilic GI disease.   [17:48] Do patients with eosinophilic GI disease do better or worse on this drug, and how do the T cells look in that trial? That HOPE Grant gave Dr. Kuang the data to ask the drug company to give her money to study it in an international cohort of patients.   [18:17] There were only 20 patients in that first NIH trial, who gave a year of their life, coming to NIH all the time. They continued to be in the study until the drug was approved for asthma.   [18:28] Dr. Kuang says the main reason the company did the Phase 3 trial, which is expensive, and the market share is not huge because it's a rare disease, is that two of the patients went to bat for this disease population.   [18:47] The two patients went and showed the business people what they looked like before, what the drug had done for them, and how their lives had changed. It wasn't the doctors or the great paper from the trial, but the patients who convinced the company.   [19:01] Dr. Kuang says she was so floored by that and moved by what they did for the community. She is grateful.   [19:24] Since the Phase 3 trial, Dr. Kuang and the other researchers realized they had not fully studied the eosinophils. They had studied them in part. They found differences in response. This inspired the second APFED HOPE Pilot Grant.   [21:19] In 2022, Dr. Kuang received a two-year APFED HOPE Pilot Grant to examine how blood eosinophils in Eosinophilic Gastrointestinal Diseases differ from those of other eosinophilic diseases and how T cells in EGIDs differ from those in food allergies.   [21:49] Dr. Kuang says normally, the biggest place of residence for eosinophils is the GI tract. That's where they are normally seen in people who do not have eosinophilic disorders.   [21:59] People who have eosinophilic disorders that attack other parts of the body, asthma, and rarely, the heart. Dr. Kuang was curious to know why one person and not the other?   [22:15] Patients who have eosinophilic GI disease often ask, How do you know this high level in the blood is not going to attack my heart or my lungs in the future? Dr. Kuang does not know.   [22:29] Dr. Kuang says, looking at the cohort at the NIH, that for many patients who have both GI organ involvement and some other space, when they first went to see a provider, their first complaint was a GI condition.   [22:54] If the doctor had only diagnosed a GI condition, nothing else, that would have been wrong. Those patients may not have been monitored as well. A third of the patients originally presented like that.   [23:11] What that meant was that we should be paying attention to patients who have GI disease who have lots of eosinophils in their blood. Moving forward, if there are new complaints, we need to investigate. We can't forget they have that.   [23:27] Dr. Kuang asks, Wouldn't it be great if we had a better tool than needing to wait? Wouldn't it be great if we had a biomarker that said the eosinophils have switched their target location and are going somewhere else?   [23:41] One way to do that is to take different groups of eosinophils and look for differences between those that never target the GI tract and those that do. In patients who have EoE, the eosinophils only target or cause problems in the esophagus.   [23:58] Are their eosinophils any different than those of a healthy person, with none of these conditions? That was the goal of that study.   [24:10] T cells are another type of white blood cell. They contain a memory of foreign things they have encountered, which allows them to glom onto flu, COVID, peanuts, pollen, that kind of thing. They remember.   [24:32] Dr. Kuang says they learned that T cells, at least in the mouse model, are required in the development of eosinophilic esophagitis. The mice in the old study, where mice were forced to develop EoE, did not get EoE if you removed their T cells.   [24:50] In the first APFED HOPE grant study, Dr. Kuang found T cells in the blood and tissue of both EGIDs and food allergy patients, but the insides of the T cells were different. The food allergy patients were children recruited by a pediatric allergist.   [25:19] In the second APFED HOPE grant study, at Northwestern, Dr. Kuang recruited her adult food allergy patients. That was a way to validate what they found in the first study and move further to better characterize those T cells in the two different diseases.   [25:47] Dr. Kuang says we're at a point where we've recruited a lot of people. She says it's amazing what people are willing to do. It's very humbling.   [26:06] Dr. Kuang's team in the lab is really great, too. To accommodate patients, they would see them after work, if that's what they had to do to isolate eosinophils. So they did that, and now they are in the process of analyzing that data. It's really exciting.   [26:28] What's exciting is that they are seeing results that show that eosinophilic GI disease patients have circulating eosinophils that are different from the eosinophils of people who don't have GI involvement, and from people who have EoE.   [26:46] The EoE patients have eosinophils different from those of healthy donors. Dr. Kuang says there's a lot of promise for perhaps unique signatures that could help define these conditions; maybe someday without biopsying, but that's a long time away.   [27:16] Dr. Kuang says they will focus on some candidate targets and try to recreate some of that in a dish with eosinophils from healthy people.   [27:26] What are the signals that lead eosinophils to do this, and can we translate that back to available drugs that target certain cytokines or other pathways, and maybe give some insight to develop drugs that target other pathways for these diseases?   [28:17] Ryan thinks it's exciting that this research is narrowing in on not only the different symptoms, but also how the eosinophils are acting differently in these populations.    [28:44] Dr. Kuang is super excited about this research. You could imagine that all eosinophils are the same, but you don't know until you look. When they looked, using the newest technology, they found there were differences.   [29:33] Dr. Kuang says it is thought that T cells respond to triggers. We don't think eosinophils have a memory for antigens. T cells do. That's one of their definitions. When T cells react to a trigger, they give out messages through cytokines or by delivery.   [30:20] Those are the messages that recruit eosinophils and other cells to come and stir up some trouble.   [30:28] In the mouse model, where you don't have the T cells, and you don't get eosinophilic esophagitis in the particular way they made it happen in a mouse, that middle messenger is gone, so the eosinophils don't know where to go.   [30:44] With drugs that take out eosinophils, you think that you've gotten rid of the cell that creates all the problems. It shouldn't matter what the message says because there's no cell there to cause the damage.   [30:58] What Dr. Kuang learned is that, at least in certain eosinophilic GI diseases, that's not true. You erase the eosinophils from the picture, but that message is still coming.   [31:10] Who's carrying out the orders? Or is that message maintaining the wall of epithelial cells in a certain way that we didn't appreciate because the eosinophils were also there?   [31:24] It's important to study both, because one is the messenger and the other is one of the actors. Whether all of the actions taken by eosinophils are bad, or maybe some of them were meant to be good, we have yet to learn.   [31:40] At the moment, we're using it as a marker for disease activity, and that may change in the future, as we learn more about the roles of these cells in the process.   [31:50] We have drugs now that target eosinophils and drugs that target T cells. Dr. Kuang thinks it's important to study both and to study the impact of these drugs on these cells.   [32:02] You could theoretically use these drugs to understand whether, if someone responds to it, what happens to these cells, and if someone doesn't respond to it, what happens to these cells, and how this disease manifests in this flavor of patients.   [32:54] Dr. Kuang says, Often in science, we take a model. We think this works this way. Then, if this works this way, we expect that if we remove this, these things should happen. We did that with the first clinical trial, with NIH patients.   [33:10] It didn't quite happen the way we thought, so we had to go looking for explanations. These were unusual setbacks. Sometimes you have unusual findings, like the food allergy part.   [33:24] When Dr. Kuang went to Northwestern, she saw different cohorts of patients than she saw at NIH. She saw people who were seen every day, which is a different spectrum than those who are selected to be enrolled in a study protocol at the NIH.   [33:42] That broadened her viewpoint. It's maybe not all food-triggered. They were seeing adults who'd never had food allergies or asthma their whole life, and they had eosinophilic esophagitis suddenly as a 50-year-old. There's a significant group of them.   [34:10] What Dr. Kuang learned and tries to be open-minded about is that where you train, what sorts of patients you see, really shape your viewpoint and thinking about the disease process and the management process.   [34:24] Dr. Kuang says she was so lucky to have experienced that at a quaternary care referral center like the NIH and at an academic center like Northwestern, where there are fantastic gastroenterologists who see so many of these patients.   [34:56] Dr. Kuang and an Allergy Fellow knew they were going to get a wonderful data set from the NIH patients they had recruited, so they thought they had better look deeply at what had been learned before with older technology, with mice and people.   [35:13] They decided to gather previous research, and that ultimately got published as an article. From that research, they learned that people did things in many different ways because there was no standard. They didn't know what the standard should be.   [35:28] Different things you do to try to get eosinophils out of tissue impact how they look, in terms of transcript, gene expression, and what messages they make to define themselves as an eosinophil.   [35:43] They also learned that because eosinophils are hard to work with, they die easily, and you can't freeze them and work on them the next day; you can introduce issues in there that have to be accounted for.   [35:59] They learned that as an eosinophil research community, they ought to come up with some standards so that they can compare future studies with each other. Dr. Kuang says it was impossible to compare the old studies that used different premises.   [36:50] Dr. Kuang says we need to be proactive in creating the datasets in a standard way so that we can compare and have a more fruitful and diverse community of data. It's hard to use the old data.   [37:57] Dr. Kuang says they get fresh blood from patients, and because eosinophils are finicky, they need to be analyzed within four hours, or preserved in a way to save whatever fragile molecules are to be studied.   [38:19] If you let it sit, it starts dying, so you won't have as many of them, and they start changing because they're not in the body. Dr. Kuang experimented with putting a tube of blood on the bench and checking it with the same test every two hours. It changes.   [38:38] Four hours is a standard to prevent the eosinophils from dying. Patients need treatment. If a patient is hospitalized and needs treatment, Dr. Kuang's team needs to be there to get a sample before treatment is started.   [39:03] The treatment impacts it, changing the situation. Much of the treatment, initially, is steroids. When you give lots of steroids, the eosinophils go away. It's no good to draw their blood then.   [39:27] Dr. Kuang also gets a urine sample. The granules of the eosinophils can get into the urine. As they study people with active disease, they want to capture granule proteins in the urine as a less invasive way to monitor activity in different disease states.   [40:04] The patient just needs to give Dr. Kuang either arm and a urine sample.   [41:04] Dr. Kuang explains, you can count your eosinophils after four hours, but to study them, they have different flags of different colors and shapes. Those colors and shapes may mean that it's an activated eosinophil, or they may have other meanings.   [41:41] Dr. Kuang focused on markers that look at whether it's going to spill its granules and some traditional markers of activation.     [41:50] Everyone chooses a different marker of activation. So they decided to look at as many as they could. One marker is not sufficient. They seem to be different in different conditions. The markers are on the surface; you need to analyze them right away.   [42:20] Then, Dr. Kuang breaks open the eosinophils and grabs the messenger RNA. They preserve it to do sequencing to read out the orders to see what this eosinophil is telling itself to make. RNA chops up messages.   [43:00] When you open an eosinophil, a protein you find is RNA, which chops up messages, destroying parts of the cell. You want to save the message. There's a brief time to analyze the eosinophil. Dr. Kuang works to preserve and read the message.   [44:04] Dr. Kuang hopes someday to run a tube of blood, look at the flags on the eosinophils, and say, "I think your eosinophilic GI disease is active," or "You have a kind of eosinophilic GI disease we need to monitor more frequently for organ damage."   [44:38] If another patient doesn't have those flags, Dr. Kuang could say, "I think the chances that you're going to have involvement elsewhere are low." That can give reassurance to folks who are worried.   [45:15] Dr. Kuang hopes that someday we can understand better why some people have food allergies vs. eosinophilic GI disease. They both have T cells, but the T cells have different packages inside with messages to deliver.   [45:34] Every day, Dr. Kuang has to tell patients she doesn't have that answer. Someday, she hopes she can tell a patient she does have that answer.   [46:35] Dr. Kuang tells about an NIH grant she's excited about and the patients she recruits after therapy, or elimination diets, to examine eosinophils and T cells, to see the impacts their treatments or diets have had on eosinophilic GI disease.   [47:18] Dr. Kuang believes there will be predictors of who will respond to an elimination diet and who will respond to steroid therapy. She hopes one day to have that, rather than going through rounds of six to eight weeks followed by a scope.   [47:34] If you have an elimination diet for six to eight weeks, every time you add back a food, you have to do a scope. Dr. Kuang says it would be great if you could be more precise ahead of time for therapy.   [47:48] Dr. Kuang says these wonderful drugs selectively take out parts of the pathway in the immune system. They provide real-life opportunities to ask, why is this important in human biology and the human immune system?   [48:15] Dr. Kuang finds the knowledge itself fascinating and useful. She hopes it informs how we choose future drugs or therapeutic avenues to get the best we can out of what we've learned, so we have more targeted ways of treating specific diseases.   [48:48] Ryan is grateful for all the research happening for the eosinophilic disease community and all the patients participating in the research. He asks Dr. Kuang how a patient can participate in research.   [49:12] There are lots of ways to be involved in research. Dr. Kuang says her patients come away from participating in research feeling good about having done it.   [49:22] Answer a survey, if that's what you have bandwidth for. Where therapies are changing, being a part of a community is good for the community, for the future, but it's good for you, too. It's healing in ways that are not steroids or biologics.   [49:58] Being part of a community is healing in ways we all need when we feel alone and bewildered. You're not alone.   [50:12] There are many ways to participate: APFED, CEGIR, individual institutions, and clinical trials. They all have different amounts of involvement. It's worthwhile to participate, not only for future patients but for yourself. They're fantastic!   [50:56] Dr. Kuang talks about the privilege as a physician of working with APFED and other organizations to do this work.   [51:09] Holly thanks Dr. Kuang for sharing all of this research and exciting information.   [51:25] Dr. Kuang is excited about what her group is doing and is hopeful. Besides showing up for this disease, we have to show up for research, in general, in this country. It's a dark time for NIH research funding.   [51:55] Dr. Kuang asks the young listeners who are thinking of choosing a field to see the potential and get into it, study this, and believe that there's going to be a future with a more nurturing research environment.   [52:36] Dr. Kuang would hate to lose generations of scientists. She says that once she was a little girl who was trying to be a scientist. Her parents had no connections with scientists or doctors, but she was able to get into research, and she thinks you can, too.   [53:48] As a graduate student, Ryan has always been interested in trying to improve things, and he sees hope on the horizon. He's very grateful to the APFED community for supporting these research HOPE Pilot Grants.   [54:17] Ryan is very grateful to Dr. Kuang for joining us today.   [54:22] For our listeners who want to learn more about eosinophilic disorders, we encourage you to visit apfed.org and check out the links in the show notes.   [54:28] If you're looking to find a specialist who treats eosinophilic disorders, we encourage you to use APFED's Specialist Finder at apfed.org/specialist.   [54:37] If you'd like to connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [54:57] Dr. Kuang thanks Ryan and Holly and says she enjoyed the conversation. Holly also thanks APFED's Education Partners GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode: Fei Li Kuang, MD, PhD, Allergist and Immunologist, Northwestern Medicine   Grants and publications discussed: Apfed.org/blog/apfed-announces-2018-hope-apfed-hope-pilot-grant-recipient/ Apfed.org/blog/fei-li-kuang-hope-pilot-grant-award/  Pubmed.ncbi.nlm.nih.gov/39213186/ Pubmed.ncbi.nlm.nih.gov/37487654/   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "I think the patients that you meet in a clinical trial, especially in a special place like NIH, occupy a space in your heart — I don't mean to be all too emotional about this — that makes you want to keep working on the subject area." — Fei Li Kuang, MD, PhD   "When I was a Fellow at the NIH, we were doing a Phase 2 clinical trial, looking at, for want of a better word, "blowing up" eosinophils in patients who have a lot of them, hypereosinophilic syndrome patients." — Fei Li Kuang, MD, PhD   "We're at a point where we've recruited a lot of people. I've had patients drive from the northern part of Illinois … come down and give me blood. It's amazing what people want to do and are willing to do. It's very humbling, actually." — Fei Li Kuang, MD, PhD   "You erase the eosinophils from the picture, but that message is still coming. Who's carrying out the orders? Or is that message maintaining the wall of epithelial cells in a certain way that we didn't appreciate because the eosinophils were also there?" — Fei Li Kuang, MD, PhD   "We need to be proactive in creating the datasets in a standard way so that we can compare and have a more fruitful and diverse community of data." — Fei Li Kuang, MD, PhD   "I think it's worthwhile to participate [in a clinical trial], not only for the future people but for yourself." — Fei Li Kuang, MD, PhD   Guest Bio: Fei Li Kuang, MD, PhD, is currently an Assistant Professor in the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine in Chicago, IL. She is a graduate of the Albert Einstein College of Medicine Medical Scientist Training Program with both a PhD in Cell Biology/Immunology and an MD.  She completed her Internal Medicine Residency at Columbia University, New York Presbyterian Hospital in New York City, she did her Fellowship in Allergy and Immunology at the National Institute of Allergy and Infectious Disease (NIAID) in Bethesda, Maryland. She is a physician-scientist who takes care of patients with eosinophilic disorders and also performs laboratory research on these disorders in her lab, often using patient samples.

A Gluten Free Podcast Episode 211Today I reflect on five gluten free life lessons from 2025. It's been a great year! There's been heaps of takeaways, things I've reflected on and struggles and wins throughout the year. I wanted to share the five biggest things I've learnt and hopefully by sharing them it will help you in your own coeliac and gluten free journey. What we'll cover: * Reflecting on last week's episode with mucosal Immunologist and Coeliac Disease Researcher at James Cook University, Dr Paul Giacomin * My hopes for coeliac disease and the gluten free diet in the future * Touching on next year's content for A Gluten Free Podcast * Importance of remaining objective and doing out best to not judge others for how they navigate their own coeliac disease and gluten free journey * 5 gluten free lessons from 2025* Importance of keeping up to date with medical check ups * Coeliac disease antibodies not coming down despite adherence to a strict gluten free diet * My osteopenia and ADHD diagnoses  * Meal prepping and planning to save time, money and energy * Asking questions and finding options depending on the level of knowledge in shared gluten and gluten free kitchens * Importance of leaving reviews for good gluten free experiences at restaurants and cafes * Staying connected with the coeliac and gluten free community * Teaser of next week's episode Links Buy Gluten Free Express by Helen Tzouganatos *This is an Amazon affiliate link. We earn a small amount when you purchase this book with our code* Enter our gluten free Christmas giveaway boxEpisode with The Coeliac Connection Founder, Jo WynneHow We Can Improve Coeliac Disease & Gluten Free Education & Awareness in the Australian Hospitality Industry with NSW Food Authority CEO, Andrew Davies Holistic Health Coach & Founder of 'The Healthy Celiac', Belinda Whelan episode Join our Podcast Facebook group Episode with Dr Paul Giacomin Episode with Dr Vincent Ho at Campbelltown Hospital Coeliac Australia's advice on monitoring and follow-up of coeliac disease 

A Gluten Free Podcast Episode 210My guest on today's episode is Mucosal Immunologist and Coeliac Disease Researcher at James Cook University, Dr Paul Giacomin. We'll talk about a study involving hookworms in the treatment for people with coeliac disease, the insights from this research and how these studies can be used to learn more about alternative treatments for coeliac disease in the future. What we'll cover: * Dr Giacomin's role at James Cook University and how he came to work in coeliac disease research * Dr Giacomin's background in working on ulcerative colitis and other inflammatory bowel diseases* How intestinal worms can play a role in our immune system and inflammation in our bodies * How the idea for hookworms in the treatment of coeliac disease came about * The positives and negatives of intestinal worms in our health * Australian trial of hookworms in the study of coeliac disease in 2008* The tolerance levels of participants in coeliac disease hookworms study in 2012 * Insights from the hookworms study and why a therapeutic follow up trial didn't happen * How hookworms can have a potential broad immune effect on other diseases and health issues * Where hookworms come from and how they are transferred to humans * Participants' experience of living with hookworms* When to visit your GP if you suspect a worm infection * How hookworms are boosting tolerance in the immune system and protection from gluten in people with coeliac disease * How hookworms could be turned into synthetic versions in the form of medications * Plans for future hookworms in the treatment for coeliac disease * Progressing hookworm treatment programs* How the findings of hookworm studies in coeliac disease be applied to IBD (ulcerative colitis, Crohn's disease, etc) * Triggers of autoimmune diseases * How to keep up to date with Dr Giacomin's research trials and get into contact with him Links Hookworms for the treatment of coeliac disease symptoms study Coeliac Australia article on Worms study Email Dr Paul Giacomin: paul.giacomin@jcu.edu.auJoin our podcast facebook group Email us: aglutenfreefamily@gmail.comThis podcast reflects personal experiences and is not medical advice. Please consult a qualified healthcare professional for individual guidance. Celiac Cruise - a 100% gluten free vacation cruise is setting sail on two Australian cruises in 2026: one to the South Pacific and the other to New Zealand. There'll of course be awesome 100% gluten free food onboard, heaps of fun stuff to do, educational talks and a community of people who understand each other. Buy your tickets here & see ya onboard gluten free fam! 

Find More Great Info From Dr. Melanie Matheu Here: SUBSTACK: https://lilscience.substack.com TIKTOK:https://www.tiktok.com/@laughterinlight YOUTUBE: https://www.youtube.com/@LaughterInLight Hawk talks with immunologist Dr. Melanie Matthew about the upcoming flu season and the devastating impact of RFK Jr as HHS Secretary. Australia experienced record-setting influenza deaths this year, with flu killing more people than COVID. The H3N2 variant mutated to evade vaccine protection, leading to unprecedented hospitalizations. Japan declared a flu epidemic five weeks early, and similar patterns are emerging in the United States.Dr. Matthew explains why flu vaccination remains critical despite mutations, reducing hospitalizations by 30-40% in adults and 70-75% in children. The conversation shifts to RFK Jr's anti-vaccine policies at HHS, where he claims no vaccine is safe and effective despite having zero background in immunology or pediatrics. His appointment, along with Marty Makary at FDA and Jay Bhattacharya at NIH, represents a complete rejection of scientific reality in favor of political ideology.The discussion covers RFK Jr's role in 88 child deaths in Samoa from measles, his vitamin A recommendations causing liver damage in Texas children, and how VAERS data is being misrepresented. Dr. Matthew details the exodus of top scientists from NIH, cancelled research grants, and terminated clinical trials that will kill patients. Forever chemicals (PFAS) are being approved for pesticides while vaccine research funding gets slashed.America faces losing measles elimination status, rising preventable disease deaths, and compromised pandemic preparedness. The CDC's COVID vaccine guidance for pregnant women has been offline for months despite evidence linking infection to preterm births and neurological damage. This administration prioritizes grift over public health, with consequences spanning decades. SUPPORT & CONNECT WITH HAWK- Support on Patreon: https://www.patreon.com/mdg650hawk- Support Hawk's Merch Store: https://hawkmerchstore.com- Connect on TikTok: https://www.tiktok.com/@hawkeyewhackamole- Connect on BlueSky: https://bsky.app/profile/mdg650hawk.bsky.social- Connect on YouTube: https://www.youtube.com/@hawkpodcasts ALL HAWK PODCASTS INFO- Additional Podcasts Available Here: https://www.hawkpodcasts.com- Listen to Hawk Podcasts On Your Favorite Platform:Spotify: https://spoti.fi/3RWeJfyApple Podcasts: https://apple.co/422GDuLYouTube: https://youtube.com/@hawkpodcastsiHeartRadio: https://ihr.fm/47vVBdPPandora: https://bit.ly/48COaTBSimplecast: https://hawk-droppings.simplecast.com- Hawk Podcasts RSS Feed: https://feeds.simplecast.com/pPVtxSNJ

In this episode of Product & Packaging Powerhouse, host Megan Young Gamble recaps her experience at Makeup in New York 2025, from day 1 and this episode focusing on day two themes of packaging innovation, sustainability, and beauty tech. She shares actionable insights from industry panels including advances in sustainable packaging (like APC Packaging's patented mono-material droppers and refillable solutions), compliance considerations, smart packaging, and the importance of consumer psychology. Startup brand Rebel Queen's all-in-one curly hair product is highlighted for its minimalistic approach, while expert Roberta Sironi provides a masterclass on mascara packaging, launching an academy for deeper industry education. Megan ties it all together with observations on tech (especially AI's growing role in beauty and packaging), and offers advice for brands considering trade shows, encouraging startups to attend for valuable connections and inspiration. Be sure to check out Day 1 Recap HERE. Access our other podcast episodes mentioned during the episodeInside MakeUp in New York: Day 1 Innovation and Tech” with Megan Young Gamble. Listen HerePackaging Design, Influence, & Integrity" with Vicki Strull, Founder, Vicki Strull Design. Listen HereThe Truth About Stress, Skincare, and Your Immune System” with Dr. Ebru Karpuzoglu, Immunologist and founder of AveSeena and ChicScience Labs. Listen HereRoundtable: Packaging, Plastics & Platforms toward Circular Economy” with Emily Anne Friedman (Recycled Plastics Editor, ICIS), Ryan Fox (Packaging Analyst, Bloomberg Intelligence) and Nicole Toole (Founder of ECGO.) Listen HereHow Connected Packaging Shapes Sustainability and Traceability” with John Dwyer, Smart Packaging Expert at Smurfit Westrock & Maurizio Carano, Innovation & Marketing Director IML @ MCC Label. Listen HereAffiliate & Other Links: [Megan Young Gamble Links][AFFILIATE] Ready to crank out your content in as little as 5 minutes? Use Castmagic, AI powered tool to take your content creation from overwhelmed to overjoyed by saving hours of developing content. Save 20 hours by Signing up today! https://get.castmagic.io/Megan [FREEBIE] Learn about “day in the life” of a Packaging Project Manager → Get our “Starter Packaging PM Freebie” [link] https://glc.ck.page/thestarterpackagingprojectmanager [FREEBIE] Access commonly referenced organizations and tools in ONE PLACE with our handy guide HERE [link] https://bit.ly/OSTPlay Subscribe & Access our Video Vault YouTube Channel [ link] https://bit.ly/GLConYouTubeJoin our Email List [link] https://glc.ck.page/55128ae04b Follow and Connect with Megan on LinkedIn [link] https://linkedin.com/in/megangambleLearn about GLC, Packaging & Project execution firm for CPG brands http://www.getlevelconsulting.comWork with Me @ GLC, Schedule Discovery Call https://calendly.com/getlevelconsulting/15-minute-insight-sessionGot a topic you'd love us to cover? Share your ideas here [link] https://bit.ly/ppptopicformContact details of Jennifer Lehto, Senior Business Development Manager at APC PackagingLinkedin - https://www.linkedin.com/in/jenniferlehtoEmail id - jenniserl@apcpackaging.comRoberta Sironi, Chief Commercial Officer at Pibiplast SpaLinkedin - https://www.linkedin.com/in/roberta-sironi-0636982/Pibiplast academy - https://pibiplast.com/certificationsQuotes and Hooks:  We've always been very conscious about our scalp health because you have to make sure your scalp is clean to help with promoting hair growth.Smart packaging gives each product their own digital passport telling consumers what it is, where it came from and what to do at the end of life.Everybody wants sustainable packaging, but the real question is: what does sustainability mean to you and your brand?Glass is heavier, costs more to ship, and is prone to breakage, so is it really deemed sustainable? Something to think about.I struggled for years to find the perfect curly hair product and I finally created it, an all-in-one that hydrates, defines, and controls frizz. (Bleema, Rebel Queen)Mascara is a really complex product, you need a lot of technicity to make the magic and make the product work. (Roberta Cerroni, Pibi Plast)AI is here to stay, and I use ChatGPT as my daily assistant all the time to help me think through things and shorten cycle times.Would I attend Makeup In New York again? Absolutely. Is it a trade show that I would recommend any company to attend? Absolutely.

Today's Headlines: Former FBI Director James Comey pled not guilty to charges of obstruction and making false statements, with his trial now set for January 5th. Meanwhile, Trump's picking new enemies, calling for Illinois Governor JB Pritzker and Chicago Mayor Brandon Johnson to be jailed for “failing to protect ICE officers.” Both fired back, with Johnson saying it's not the first time Trump's tried to have a Black man unjustly arrested. Adding to that authoritarian flavor, new data shows nearly a quarter of FBI agents are now focused primarily on immigration enforcement — a number that hits 40% in some major field offices. Donald Trump announced that Israel and Hamas have finally agreed on the first phase of their ceasefire plan — Israel will pull back troops, hostages will go home, and prisoners will walk free. Qatar and Hamas added that the deal also opens the gates for aid to enter Gaza. At the same time, his administration quietly inked an executive agreement giving Qatar near–NATO-level security guarantees — a move that normally requires Senate approval, but apparently we're skipping that part now. In economic news, gold prices just hit a record high of $4,000 an ounce — the strongest rally since 1979 — while the dollar is down more than 9% this year, signaling a crisis of confidence in U.S. institutions. A 29-year-old Florida man was arrested for starting the January wildfires that destroyed over 17,000 homes in Malibu and Palisades, killing 30 people. And to end on a rare uplifting note, 64-year-old immunologist Fred Ramsdell won the Nobel Prize in Medicine — learning the news only after returning from an off-the-grid Montana vacation. Truly the anti-Trump. Resources/Articles mentioned in this episode: NYT: Comey Pleads Not Guilty and Will Seek to Dismiss Charges as Vindictive Axios: Trump baselessly calls for Pritzker, Chicago mayor to be jailed WaPo: A quarter of FBI agents are assigned to immigration enforcement, per FBI data WSJ: Trump Says Middle East Deal Is ‘Very Close,' May Travel to Region This Week Axios: U.S. security guarantee for Qatar sparks jealousy and confusion Axios: Gold's rally signals investors' eroding trust in the U.S. AP News: Authorities charge man with sparking deadly January wildfire that leveled LA neighborhoods Wired:Scientist Who Was Offline 'Living His Best Life' Stunned by Nobel Prize Win Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

DR. Juanita Mora...Immunologist and spokesperson for the American Lung Asso on News Radio KKOBSee omnystudio.com/listener for privacy information.

In this episode of the Product & Packaging Powerhouse, host Megan Young Gamble sits down with Dr. Ebru Karpuzoglu, an immunologist, molecular medicine expert, wellness coach, and founder of AveSeena and ChicScience Labs. Dr. Ebru explains the critical impact of stress and inflammation, especially “inflammaging” on skin health, and why acute inflammation is necessary while chronic or persistent low-level inflammation is harmful. She shares her journey combining science with intentional daily rituals and discusses her focus on creating multitasking skincare products that address inflammatory issues, especially for busy women. Dr. Ebru also highlights the importance of compliance, GMPs (Good Manufacturing Practices) and not following fleeting beauty trends, urging new brands to focus on targeted needs and sound partnerships. The episode covers myths in the beauty industry (like “clean” meaning chemical-free), TikTok trends to avoid, and how packaging matters but real results keep customers loyal. There's also a fun sci-fi rapid-fire round at the end!Affiliate & Other Links: [Megan Young Gamble Links][AFFILIATE] Ready to crank out your content in as little as 5 minutes? Use Castmagic, AI powered tool to take your content creation from overwhelmed to overjoyed by saving hours of developing content. Save 20 hours by Signing up today! https://get.castmagic.io/Megan [FREEBIE] Learn about “day in the life” of a Packaging Project Manager → Get our “Starter Packaging PM Freebie” [link] https://glc.ck.page/thestarterpackagingprojectmanager [FREEBIE] Access commonly referenced organizations and tools in ONE PLACE with our handy guide HERE [link] https://bit.ly/OSTPlay Subscribe & Access our Video Vault YouTube Channel [ link] https://bit.ly/GLConYouTubeJoin our Email List [link] https://glc.ck.page/55128ae04b Follow and Connect with Megan on LinkedIn [link] https://linkedin.com/in/megangambleLearn about GLC, Packaging & Project execution firm for CPG brands http://www.getlevelconsulting.comWork with Me @ GLC, Schedule Discovery Call https://calendly.com/getlevelconsulting/15-minute-insight-sessionGot a topic you'd love us to cover? Share your ideas here [link] https://bit.ly/ppptopicform[Powerhouse Guest Dr Ebru's LINKS]LinkedIn: https://www.linkedin.com/in/ebrukarpuzoglu/Company Website: www.aveseena.comCompany Website: www.chicsciencelabs.com Additional Resource [Podcast] "MoCRA, Misconceptions and Regulatory Risk" - Ariana Farina, Regulatory Consultant @ Ariana Farina. Listen here Episode Quotes:.Don't follow the trends, find your niche, find a good partner, and be intentional.Clean doesn't mean chemical-free. Everything is a chemical, even waterEverything inside is mirroring outsideYou're an open system. Your skin is your outer layer, but it's designed to feel everything.If you don't have inflammation, you will die. Inflammation keeps us alive.Chronic stress induces inflammation, and you see it right away on your face and in how your body feels.Inflammaging is that silent, low-level inflammation that slowly makes you look tired and age faster.Science doesn't work against you, it works for you.Be ethical, be transparent. When you put your head on the pillow at night, you should know you did it right.

In this special Tick Boot Camp Podcast episode recorded live at Project Lab Coat during New York Fashion Week (NYFW), we sit down with Dr. Michal “Mikki” Caspi Tal, Principal Scientist in the Department of Biological Engineering at MIT and Associate Scientific Director of the MIT Center for Gynepathology Research. Dr. Tal is an immunologist and immunoengineer whose groundbreaking research focuses on the connections between infections and chronic diseases, including Lyme disease and long COVID. At her Tal Research Group lab, she studies why some people recover quickly after infection while others develop chronic illness, with a focus on the immune system's different responses in men and women. What You'll Learn in This Episode How Dr. Tal's lab uses mouse models of chronic Lyme and a large clinical study to take a deeper look at Lyme disease. Why some patients make a protective immune response while others develop catastrophic responses like dysautonomia, MCAS, gynecological issues, or clotting disorders. How her team is moving beyond “yes/no” antibody tests to create new biomarker diagnostics that can guide treatments. Why sex differences matter in chronic illness and why women are more likely to experience long-term symptoms after infection. How her research could lead to more personalized treatment approaches for Lyme disease patients by grouping individuals based on immune response patterns. What samples (blood, saliva, sweat, tissue) her team is collecting at MIT to uncover new insights into chronic Lyme disease. Why this research brings hope to Lyme patients who feel unseen and unheard. About Dr. Michal Caspi Tal Principal Scientist, MIT Department of Biological Engineering Associate Scientific Director, MIT Center for Gynepathology Research Focus areas: Lyme disease, long COVID, chronic inflammatory diseases, sex differences in immune response, predictive diagnostics Background: PhD in Immunobiology from Yale (mentored by Dr. Akiko Iwasaki), postdoctoral training at Stanford (Irving Weissman lab), infectious disease research leader at Stanford's Institute for Stem Cell Biology and Regenerative Medicine. Awards: NIH NIAID F31 and F32 Fellowships, Bay Area Lyme Foundation Emerging Leader Award About Project Lab Coat at New York Fashion Week Project Lab Coat was a groundbreaking event held on September 13, 2025, during New York Fashion Week (NYFW). The show brought together prominent celebrities, researchers, doctors, and advocates who were invited to walk the runway to spotlight Lyme disease and raise funds for Lyme disease research. For the first time, the global visibility of NYFW was used to highlight one of the fastest-growing infectious diseases in the world. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen, together with Dr. Tal, walked the runway at Project Lab Coat, joining leaders from medicine, science, entertainment, and advocacy. Project Lab Coat demonstrated the power of mainstream platforms to bring awareness, credibility, and resources to the fight against Lyme disease. Why This Episode Matters For too long, chronic Lyme patients have been told their symptoms are “all in their head.” Dr. Tal's work at MIT proves otherwise by measuring the real biological differences in immune system responses. This research not only validates patients' experiences but also charts a course toward better diagnostics, clinical trials, and personalized treatments.

9/18/25: Immunologist Dr. Jonathan Bayuk: covid & flu shots & RFK, Jr. Gazette & Gfld Recorder Ex Ed Dan Crowlwy: covering elections & bullets in Belchertown. Rabbah Riqi Kosovske: Jewish High Holidays & the War in Gaza. Nhmptn Jazz Festival Pres Ruth Griggs w/ the extraordinary Zaccai Curtis.

Warner Carr, MD, Allergist and Immunologist at the Allergy and Asthma Associates of Southern California, discusses the mastocytosis control test and its implications for physicians.

Pop Culture Green Room co-host Blair sits down with Dr. Ebru Karpuzoglu, a brilliant immunologist and founder of AveSeena, to talk about how science can make your skincare smarter.We chat about:Why your skin's immune health matters just as much as your skincare routine, how she developed her skin care line AveSeena, and how she went from the research lab to creating a clean beauty brand that's gentle, effective, and actually feels amazing to use.AveSeena website: https://www.aveseena.com/AveSeena on InstagramAveSeena on Facebook#AveSeena #CleanBeauty #SkincareTips #GlowingSkin #HealthySkin #ScienceBasedBeauty #SkinCareRoutine #SensitiveSkinCare #BeautyChat #thepopculturegreenroom #fyp #explorepage #popculturepodcast

Today's guest is Dr. Ebru, a dynamic force in the world of skincare. With a background in molecular medicine, immunology, and cosmetic chemistry, she created her skincare line, AveSeena, from the ground up. She was one of the first to connect inflammation, “inflammaging,” the immune system, and the skin microbiome in the development of her products. Beyond her scientific expertise, Dr. Ebru brings an upbeat energy and a wealth of valuable insights that you won't want to miss.

Professor Luke O'Neill, Immunologist at Trinity College Dublin and Newstalk regular joins Kieran to place his favourite book on The Hard Shoulder Bookshelf!

Pat Fitzgerald-Bocarsly moved from California to Boston and then settled with her husband in New Jersey where she and he both serve in academics at Rutgers and Princeton (in that order). Three adult children, 6 grandkids and a life of adventure and religion and successes in many areas of life. You will enjoy meeting this provost of Rutgers with much more to say about her worries and her hopes for the future. Historical marker includes the First Crusade, Boeing, and Versace and Twitter.Support the showThanks for listening. Please share the pod with your mates, and feel free to comment right here! Write to Bob on his email -- bobmendo@AOL.comLink to https://www.facebook.com/profile.php?id=100078996765315 on Facebook. Bobs Your Uncle features the opinions of Bob Mendelsohn and any of his guests.To financially support the podcast, go to the Patreon site and choose Gold, Silver or Bronze levels. Thanks for that! https://www.patreon.com/BobsYourUncle To read Bob's 1999 autobiography, click this link https://bit.ly/StoryBob To see photos of any of Bob's guests, they are all on an album on his Flickr site click here: https://www.flickr.com/photos/bobmendo/albums/72177720296857670

An immunologist giving evidence at the inquiry into the government's Covid-19 response, has been questioned on claims the debate around mRNA vaccines was shut down during the pandemic. Reporter Lucy Xia has more.

The Allergy Truth: What's Really Making You Sick? Dr. Tania Elliott, MD – Board-Certified Allergist, Immunologist & Internal  In this eye-opening episode, Hurricane H welcomes Dr. Tania Elliott, a nationally recognized board-certified allergist, immunologist, and internal medicine physician. Known for her expertise in diagnosing and managing complex allergic and immune-related conditions, Dr. Elliott has been a trusted medical voice on platforms like NBC, CBS, and The Dr. Oz Show. She combines clinical experience with clear, compassionate communication to help patients and audiences understand their bodies better. Together, we uncover the truth behind one of today's most underestimated health issues: allergies. From seasonal sneezing fits to food intolerance, unexplained fatigue, skin flare-ups, and respiratory distress — could allergies be the hidden culprit? Dr. Elliott sheds light on what's really making people sick, how our immune systems are reacting to modern environments, and what you can do to take control of your health.

The Allergy Truth: What's Really Making You Sick? Dr. Tania Elliott, MD – Board-Certified Allergist, Immunologist & Internal  In this eye-opening episode, Hurricane H welcomes Dr. Tania Elliott, a nationally recognized board-certified allergist, immunologist, and internal medicine physician. Known for her expertise in diagnosing and managing complex allergic and immune-related conditions, Dr. Elliott has been a trusted medical voice on platforms like NBC, CBS, and The Dr. Oz Show. She combines clinical experience with clear, compassionate communication to help patients and audiences understand their bodies better. Together, we uncover the truth behind one of today's most underestimated health issues: allergies. From seasonal sneezing fits to food intolerance, unexplained fatigue, skin flare-ups, and respiratory distress — could allergies be the hidden culprit? Dr. Elliott sheds light on what's really making people sick, how our immune systems are reacting to modern environments, and what you can do to take control of your health.

In this episode of The Cognitive Revolution, Professor Derya Unutmaz, a biomedical scientist and human immunologist at the Jackson Laboratory, discusses his groundbreaking research in aging and cancer immunotherapy. As a ChatGPT Pro grant awardee, Derya provides insights into the integration of AI with biomedical sciences, emphasizing how advanced AI models are transforming hypothesis generation, data analysis, and scientific discovery. He also covers his early passion for computers and programming, the inspiration he derived from Ray Kurzweil's work, and how AI is democratizing science by enabling even young researchers to make significant contributions. Derya outlines his vision for a future with ASI, discussing potential societal impacts, the need for regulatory AI models, and the promise of a golden age where diseases are cured, aging is reversed, and resource scarcity is a thing of the past. Finally, he dreams about the long-term future, imagining a life of exploration and discovery across the cosmos. SPONSORS: SafeBase: SafeBase is the leading trust-centered platform for enterprise security. Streamline workflows, automate questionnaire responses, and integrate with tools like Slack and Salesforce to eliminate friction in the review process. With rich analytics and customizable settings, SafeBase scales to complex use cases while showcasing security's impact on deal acceleration. Trusted by companies like OpenAI, SafeBase ensures value in just 16 days post-launch. Learn more at https://safebase.io/podcast Oracle Cloud Infrastructure (OCI): Oracle's next-generation cloud platform delivers blazing-fast AI and ML performance with 50% less for compute and 80% less for outbound networking compared to other cloud providers. OCI powers industry leaders like Vodafone and Thomson Reuters with secure infrastructure and application development capabilities. New U.S. customers can get their cloud bill cut in half by switching to OCI before March 31, 2024 at https://oracle.com/cognitive Shopify: Shopify is revolutionizing online selling with its market-leading checkout system and robust API ecosystem. Its exclusive library of cutting-edge AI apps empowers e-commerce businesses to thrive in a competitive market. Cognitive Revolution listeners can try Shopify for just $1 per month at https://shopify.com/cognitive NetSuite: Over 41,000 businesses trust NetSuite by Oracle, the #1 cloud ERP, to future-proof their operations. With a unified platform for accounting, financial management, inventory, and HR, NetSuite provides real-time insights and forecasting to help you make quick, informed decisions. Whether you're earning millions or hundreds of millions, NetSuite empowers you to tackle challenges and seize opportunities. Download the free CFO's guide to AI and machine learning at https://netsuite.com/cognitive RECOMMENDED PODCAST: Second Opinion. Join Christina Farr, Ash Zenooz and Luba Greenwood as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Spotify: https://open.spotify.com/show/0A8NwQE976s32zdBbZw6bv Apple: https://podcasts.apple.com/us/podcast/second-opinion-with-christina-farr-ash-zenooz-md-luba/id1759267211 YouTube: https://www.youtube.com/@SecondOpinionwithChristinaFarr

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mark Mamula, an immunologist and professor at Yale University School of Medicine, to discuss his groundbreaking work in canine cancer immunotherapy. Dr. Mamula shares how his background in autoimmune diseases led him to develop an experimental vaccine targeting EGFR and HER2 proteins in dogs with cancer. He explains the science behind this therapy, its clinical trial progress, and its potential to improve survival outcomes for cancers such as osteosarcoma and hemangiosarcoma. They also explore the challenges of bringing new therapies to veterinary medicine, the role of combination treatments, and the importance of accessible, cost-effective options for pet owners. Tune in for an insightful conversation on the evolving landscape of canine cancer treatment and the promising future of immunotherapy.

Dr Mark Dykewicz- Allergy and Immunology, Internal Medicine SSM Health SLUCare Physician Group, joins Megan Lynch as The Food and Drug Administration this week upgraded a food recall for Lay's Potato chips to the highest risk level.

Send us a textClickbait headlines, shady supplements, and sketchy policies—oh my! Enter Dr. Andrea Love, an immunologist and all-around impressive human.Frustrated by medical misconceptions, Andrea founded Immunologic with a mission to replace fear with curiosity and equip people with critical thinking skills.Medical organizations and safety or science agencies each have distinct roles, but their flexibility is often shaped by government policies. To navigate their guidance, rely on 2-3 solid, reputable (and relevant) resources—trusting just one source is like building a table with only one leg: it won't hold up.Research doesn't happen overnight. It's a marathon, not a TikTok trend. And as demographics represented become more overall present, it takes time for that to reflect. With the wave of attention to menopause in the media, women are the primary target of the wild west of unregulated supplements. Dr. Love warns about “Hormone hacks”. These claims are red flags built for sales, not science.Providers are in the trenches; how can they help patients survive this predatory landscape?By walking people through data (not fear) and translating science into—as Dr. Love bluntly puts it—something a 4th grader can understand.Some experts overuse jargon or discredit others. Don't get caught up in the Huberman Hype and be critical of red flags: conflicts of interest, excessive jargon, and acting like the authority on everything.Remember: Real experts know their limits—and yours. I had to cut this one short so you can soak up this wealth of information. Stay tuned for Part 2 of this interview next week. What's Inside:Medical misconceptions in the media.Who to trust in the sea of medical orgs, providers, safety orgs, and science communicators?Red Flags in the media and supplement industryGetting critical and understanding science and research.It can feel like everywhere you look there are big, bold medical claims! How can YOU solve this huge problem you didn't even know you had TODAY!? Are you guilty of trusting anyone with a PhD using big fancy words? How has this episode informed you on moving forward with science literacy? Let me know on Insta!Mentioned In This Episode:Andrea C. Love, PhD (@dr.andrealove) on Instagram Dr. Andrea LoveJen Gunter (@drjengunter) on InstagramJen — The Eco WellDanielle Shine (@danielleshine.dietitian) on InstagramDr Michelle Wong - Beauty Science (@labmuffinbeautyscience) on InstagramFit Feels Good (@oonaghduncan) on Instagraminfo@fitfeelsgood.com 

Dr Denis Bouboulis, an allergist and immunologist from the US, has been diagnosing and treating PANS PANDAS for nearly 20 years. He talks about the "wild card" of Covid and how Long Covid could be linked to underlying vector-borne infections, such as Lyme disease. In the States, there is more awareness and testing around Lyme and co than in the UK, and it certainly made me think about what could be missing from our children's treatment - especially those who do not seem to get significantly better or frequently relapse. He also discusses how short-term antibiotics to treat PANS/PANDAS is a "false narrative" and how long-term treatment is key for recovery. Although based in the States, he works via telemedicine across the world. Here he is on Linkedin https://www.linkedin.com/in/dr-denis-bouboulis/recent-activity/all/

Have you ever wondered how our body fights off infection and disease? It's a pretty cool process. Our guest, Dr. Namita Gandi, is an immunologist and she is going to explain the secret weapon that your immune system posseses to keep you healthy.   #sciencepodcast #sciencepodcastforkids #sciencecareeers #stem #stemcareers #stempodcastforkids #womeninstem #podcast Every episode of this award-winning science podcast for kids takes you behind the scenes of a scientist, engineer, or expert's daily job. Packed with fun facts, intriguing information, and lots of laughs, this podcast aims to educate as well as inspire.  The best part is that each episode gives our listeners a challenge to learn more. This week's challenge is to think about this: Think about a piece of fruit. How is it different from the inside and the outside?  Find more information on our website: www.solveitsciencepodcastforkids.com (https://solveitsciencepodcastforkids.com/)  Follow us on: Facebook @ kidssolve (https://www.facebook.com/KidsSolve) Instagram @kidssolve (https://www.instagram.com/kidssolve/) X @kidssolve (https://x.com/KidsSolve)  

Dr. Timothy Buckey, MD, MBE, discusses how medical ethics impact every patient encounter and offers practical advice on how to implement into clinical practice. (November 13, 2024)

This is a free preview of a paid episode. To hear more, visit chrisryan.substack.comShawn Kubli is an American immunologist and surfer, currently land-locked in Toronto, Ontario. Working in the biotech industry for Treadwell Therapeutics, his research group develops living drugs – cell therapy – that harness the intrinsic power of the immune system to fight cancer. Shawn's academic background in evolutionary genetics and ecology shape …

MSNBC's Ari Melber hosts "The Beat" on Tuesday, June 18 and reports on the lead-up to the first presidential debate of the 2024 election. Plus, Dr. Anthony Fauci joins for a special "Summit Series" interview. Chai Komanduri and Judge John Jones III join.

Immunologist & Vaccinologist, Dr. Robert Malone, MD, gives an expose on his extensive background in vaccine development from his significant contribution to the invention of mRNA technology to his involvement in the real life ongoing case about the injury cover-up from the MMR vaccine, portrayed in the film Protocol 7. Hear first hand why he believes gain-of-function research is one of the biggest threats to humanity.

An update on the current bird flu outbreak: it's still infecting wild birds, mammals and now several farmworkers in the United States. The virus does not appear to be transmitted between humans, but can we prevent further spread? And what are public health officials doing to contain it? Immunologist and virologist Rick Bright has been studying the bird flu for decades and tells Dr. Sanjay Gupta why he thinks more action is needed and who he thinks should be leading the charge. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr Charles B. Simone.  I am an Internist, a  Medical Oncologist, a Radiation Oncologist, and an Immunologist, trained at the Cleveland Clinic, the National Cancer Institute, and the University of Pennsylvania. Dr. Simone begins by letting us know that the virus was created on purpose and the DOD created the vaccine and then it was sold to Big Pharma. This was planned false flag to remove the President of the US. The cures have always existed but Big Pharma has kept it from the people. Now the people are learning that they do exist and that the Big Pharma and the Gov has been trying to hide from us.